Martin Currie LTD Merck & Co., Inc. Transaction History

Martin Currie LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $6.14 Million - $6.81 Million	-85,544 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $614,346 - $696,365	-8,395 Reduced 8.94%	85,544 $7.1 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $3.33 Million - $3.79 Million	-47,339 Reduced 33.51%	93,939 $7.26 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $7.44 Million - $8.4 Million	-95,965 Reduced 40.45%	141,278 $13 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $1.39 Million - $1.51 Million	18,249 Added 8.33%	237,243 $20 Million

Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $2,653 - $3,100	38 Added 0.02%	218,994 $18.4 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $10.6 Million - $12 Million	-151,633 Reduced 40.92%	218,956 $18.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $4.2 Million - $4.87 Million	64,370 Added 21.02%	370,589 $28.3 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $4.3 Million - $5.05 Million	74,499 Added 32.15%	306,219 $21.7 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $16,062 - $18,871	316 Added 0.14%	231,720 $14.1 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $75,420 - $87,660	1,480 Added 0.64%	231,404 $12.6 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $2 Million - $2.39 Million	38,824 Added 20.32%	229,924 $12.9 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $293,350 - $315,650	5,000 Added 2.69%	191,100 $12.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	186,100	186,100 $11.9 Million

3,768

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

Stay updated on Martin Currie LTD with notifications on news.